Navigation Links
Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
Date:3/2/2009

patient's immune system to attack the tumor by specifically destroying those cells bound by MORAb-009. The Phase II clinical trial is supported by safety data and clinical observations from a recently completed Phase I trial of MORAb-009 in patients with mesothelin-bearing tumors, including pancreatic, mesothelioma and ovarian cancers as well as data derived from preclinical models.

Mesothelioma develops in the chest outside the lungs, usually growing asymptomatically before it is discovered. It is especially common in people who have been exposed to asbestos, such as ship yard workers and pipefitters. Each year, an estimated 2,500 to 3,000 people are diagnosed with mesothelioma in the United States and it accounts for more than 2,500 deaths in the United States. It accounts for approximately 43,000 deaths worldwide each year.

For more information about the trial, call 1-888-422-4743.

About Morphotek

Morphotek, Inc., a subsidiary of Eisai Corporation of North America, is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology. The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications. The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease. For more information, please visit http://www.morphotek.com.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... International plc (NASDAQ: ENDP ) (TSX: ENL) announced today ... present a corporate overview at the UBS Global Healthcare Conference ... May 20, 2015 at 11:00 a.m. ET.  ... be available on the Company,s website at www.endo.com . ... event. Participants should allow approximately 10 minutes prior to the ...
(Date:5/6/2015)... BALTIMORE , May 6, 2015   University ... LLC announced today the signing of an exclusive ... of Maryland, Baltimore (UMB) to develop diagnostics to detect ... and Crohn,s disease (CD). Drs. Florian Fricke ... while both were with the University of Maryland School ...
(Date:5/6/2015)... Park Systems , world-leader in atomic ... vacuum AFM system in the market that meets the ... Park NX-Hivac is ideal for academic and industrial customers ... doped semiconductor processing where more highly sophisticated failure analysis ... scanning spreading resistance microscopy (SSRM) of Park NX-Hivac enables ...
(Date:5/6/2015)... SHANGHAI , May 6, 2015 Dr ... institute of Massey University, will deliver a speech at the ... 24-25 at the Shanghai New Expo Center.  ... he will introduce to attendees the topic: ,Potato Starch: ... Bulk-ingredients and Smart Foods., Co-editor of a ...
Breaking Biology Technology:Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 2Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 3Potato Starch: A Potential Source for the Creation of Next Generation Bulk-ingredients and Smart Foods 2
... Corporation has announced the,appointment of David A. Mann to ... Chairman of the Board,s audit committee., "Dave,s years ... biotechnology sector are an invaluable asset to Omeros,",stated Gregory ... an,important addition to our Board, and I expect that ...
... BN,ImmunoTherapeutics, Inc. has entered into a ... in the United States. Under the Cooperative,Research ... BN,ImmunoTherapeutics will jointly develop new immunotherapies for ... BN ImmunoTherapeutics has,rights to exclusively license intellectual ...
... Conference Call & Webcast Today at 2:00 p.m. CET, ... in the field of human gene therapy,today reported its results ... - Positive results of pivotal trial for Glybera(R) (AMT-011) ... treatment of Non-Alcoholic Steatotic Hepatitis - License for ...
Cached Biology Technology:Omeros Appoints David A. Mann to its Board of Directors 2BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 2BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 3Amsterdam Molecular Therapeutics Reports Half Year Results 2008 2Amsterdam Molecular Therapeutics Reports Half Year Results 2008 3Amsterdam Molecular Therapeutics Reports Half Year Results 2008 4
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... -- At its 2015 ACMG Annual Clinical Genetics Meeting ... American College of Medical Genetics and Genomics (ACMG) announced ... Members of the ACMG Board of Directors serve as ... its policies and programs. ACMG is the national organization ... eventful time in medical genetics and genomics.  We are ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... of the most debilitating symptoms of migraine and affects 80 ... physician, Dr. Zoltan Medgyessy of the Berolina Clinic in Lohne, ... antiemetic point on the inner wrist with an acupressure wristband ... migraine sufferers. He will be presenting his findings to ...
... and an international group of scientists have created ... losing pieces. Scientists led by Jianguo "Jack" Liu, ... built an integrated way to study a world that ... socioeconomic and environmental interactions over distances. They say "telecoupling" ...
... Efforts currently underway at the Energy Department,s National Renewable ... the research, development and testing of hydrogen and fuel ... of support from the Department,s Fuel Cell Technologies Office ... Hybrid Vehicles Advanced (FCHV-adv) on loan from Toyota. ...
Cached Biology News:Efficacy of acupressure to relieve migraine nausea presented at International Headache Congress 2Telecoupling pulls pieces of sustainability puzzle together 2Telecoupling pulls pieces of sustainability puzzle together 3NREL drives toward the future with fuel cell EVs 2NREL drives toward the future with fuel cell EVs 3NREL drives toward the future with fuel cell EVs 4
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
D-biotin *50 mM aqueous solution* Secondary Detection Biotin–Avidin Detection Reagents Other...
Endothelin-converting enzyme 1 (EC 3.4.24.71) (ECE-1). [Source:Uniprot/SWISSPROT;Acc:P42892] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: